These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Which drugs to prescribe. Ebell M Fam Pract Manag; 2006 Sep; 13(8):23-4; author reply 24. PubMed ID: 17024760 [No Abstract] [Full Text] [Related]
5. [What is the aim of uncontrolled phase IV studies on efficacy?]. de Abajo FJ; FrÃas J; Garijo B; Lopo CR Med Clin (Barc); 1989 Jun; 93(1):38-9. PubMed ID: 2770375 [No Abstract] [Full Text] [Related]
6. Biotechs go generic: the same but different. Ledford H Nature; 2007 Sep; 449(7160):274-6. PubMed ID: 17882194 [No Abstract] [Full Text] [Related]
7. An overview of how drugs are designed and developed. Gallimore D Nurs Times; 2006 Nov 21-27; 102(47):30-1. PubMed ID: 17153043 [TBL] [Abstract][Full Text] [Related]
10. Mandatory post marketing studies. Somberg J Am J Ther; 2007; 14(4):321. PubMed ID: 17667203 [No Abstract] [Full Text] [Related]
11. New law gives FDA more influence to monitor drug safety. Wadman M Nat Med; 2007 Nov; 13(11):1269. PubMed ID: 17987008 [No Abstract] [Full Text] [Related]
12. Cause and effect? Assessing postmarketing safety studies as evidence of causation in products liability cases. Shea LL; Hanson A; Guglielmetti TM; Levy K Food Drug Law J; 2007; 62(3):445-72. PubMed ID: 17915388 [No Abstract] [Full Text] [Related]
13. Clinical evaluations clinical investigations under the amended Medical Device Directive. Dannhorn DR; Schwabedissen H Med Device Technol; 2008 Sep; 19(5):16-8, 20. PubMed ID: 18947145 [TBL] [Abstract][Full Text] [Related]
15. [The Medical Products Agency is responsible for the control of medical technological products: we need more active medical professionals reporting shortages]. Philipson L Lakartidningen; 2008 Mar 5-11; 105(10):746-7. PubMed ID: 18422241 [No Abstract] [Full Text] [Related]
16. FDA cracks down on labeling, initiates trial result reporting. Osborne R; Waltz E Nat Biotechnol; 2008 Nov; 26(11):1203-4. PubMed ID: 18997742 [No Abstract] [Full Text] [Related]
17. [Postmarketing surveillance studies in community pharmacies]. Nieber K; Lehmacher W Med Monatsschr Pharm; 2009 Aug; 32(8):301-6. PubMed ID: 19777737 [TBL] [Abstract][Full Text] [Related]
18. Confidentiality laws and secrecy in medical research: improving public access to data on drug safety. Kesselheim AS; Mello MM Health Aff (Millwood); 2007; 26(2):483-91. PubMed ID: 17339677 [TBL] [Abstract][Full Text] [Related]
19. Rotavirus immunisation in Africa: a perspective re-visited. Steele D Afr J Health Sci; 2002; 9(3-4):113-6. PubMed ID: 17298153 [No Abstract] [Full Text] [Related]
20. Vioxx's history and the need for better procedures and better testing. Gilhooley M Seton Hall Law Rev; 2007; 37(4):941-68. PubMed ID: 18363218 [No Abstract] [Full Text] [Related] [Next] [New Search]